Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/17504
Full metadata record
DC FieldValueLanguage
dc.contributor.authorJo, Helen E-
dc.contributor.authorTroy, Lauren K-
dc.contributor.authorKeir, Gregory-
dc.contributor.authorChambers, Daniel C-
dc.contributor.authorHolland, Anne-
dc.contributor.authorGoh, Nicole S L-
dc.contributor.authorWilsher, Margaret-
dc.contributor.authorde Boer, Sally-
dc.contributor.authorMoodley, Yuben-
dc.contributor.authorGrainge, Christopher-
dc.contributor.authorWhitford, Helen-
dc.contributor.authorChapman, Sally-
dc.contributor.authorReynolds, Paul N-
dc.contributor.authorGlaspole, Ian-
dc.contributor.authorBeatson, David-
dc.contributor.authorJones, Leonie-
dc.contributor.authorHopkins, Peter-
dc.contributor.authorCorte, Tamera J-
dc.date2017-
dc.date.accessioned2018-04-24T05:33:15Z-
dc.date.available2018-04-24T05:33:15Z-
dc.date.issued2017-10-
dc.identifier.citationRespirology (Carlton, Vic.) 2017; 22(7): 1436-1458en_US
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/17504-
dc.description.abstractIdiopathic pulmonary fibrosis (IPF) is a fibrosing interstitial lung disease (ILD) of unknown aetiology with a median survival of only 2-5 years. It is characterized by progressive dyspnoea and worsening lung function, ultimately resulting in death. Until recently, there were no effective therapies for IPF; however, with the publication of two landmark clinical trials in 2014, the anti-fibrotic therapies, nintedanib and pirfenidone, have gained widespread approval. This position paper aims to highlight the current evidence for the treatment of IPF, with particular application to the Australian and New Zealand population. We also consider areas in which evidence is currently lacking, especially with regard to the broader IPF severity spectrum and treatment of co-morbid conditions. The utility of non-pharmacological therapies including pulmonary rehabilitation, oxygen as well as symptom management thought to be important in the holistic care of IPF patients are also discussed.en_US
dc.language.isoeng-
dc.subjectnintedanib, pirfenidoneen_US
dc.subjectidiopathic pulmonary fibrosisen_US
dc.subjectinterstitial lung diseaseen_US
dc.subjecttreatmenten_US
dc.titleTreatment of idiopathic pulmonary fibrosis in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleRespirology (Carlton, Vic.)en_US
dc.identifier.affiliationDepartment of Respiratory Medicine, Royal Prince Alfred Hospital, Sydney, NSW, Australiaen_US
dc.identifier.affiliationRespiratory and Sleep Medicineen_US
dc.identifier.affiliationDepartment of Respiratory Medicine, Auckland District Health Board, Auckland, New Zealanden_US
dc.identifier.affiliationFaculty of Medicine, University of Sydney, Sydney, NSW, Australiaen_US
dc.identifier.affiliationDepartment of Respiratory Medicine, Princess Alexandra Hospital, Brisbane, QLD, Australiaen_US
dc.identifier.affiliationDepartment of Respiratory Medicine, The Prince Charles Hospital, Brisbane, QLD, Australiaen_US
dc.identifier.affiliationDepartment of Physiotherapy, The Alfred Hospital, Melbourne, Victoria, Australiaen_US
dc.identifier.affiliationDepartment of Respiratory Medicine, Fiona Stanley Hospital, Perth, WA, Australiaen_US
dc.identifier.affiliationDepartment of Respiratory Medicine, John Hunter Hospital, Newcastle, NSW, Australiaen_US
dc.identifier.affiliationDepartment of Respiratory Medicine, The Alfred Hospital, Melbourne, Victoria, Australiaen_US
dc.identifier.affiliationDepartment of Respiratory Medicine, Royal Adelaide Hospital, Adelaide, SA, Australiaen_US
dc.identifier.affiliationPatient Advocate, Auckland, New Zealanden_US
dc.identifier.doi10.1111/resp.13146en_US
dc.type.contentTexten_US
dc.identifier.orcid0000-0003-1183-2729en_US
dc.identifier.orcid0000-0002-5118-2890en_US
dc.identifier.pubmedid28845557-
dc.type.austinJournal Article-
local.name.researcherGoh, Nicole S L
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.languageiso639-1en-
item.openairetypeJournal Article-
crisitem.author.deptRespiratory and Sleep Medicine-
crisitem.author.deptInstitute for Breathing and Sleep-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

4
checked on Mar 28, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.